Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuroligin-1 (NLGN1) is a postsynaptic cell adhesion protein encoded by the NLGN1 gene, belonging to the neuroligin family. It predominantly localizes to the postsynaptic membranes of excitatory (glutamatergic) synapses, where it acts as a ligand for presynaptic β-neurexins. Through trans-synaptic interactions, NLGN1 plays a crucial role in the formation, differentiation, and modulation of synapses in the central nervous system. Regulation of NLGN1, including its cleavage and phosphorylation by receptor tyrosine kinases such as TrkB, affects synaptic structure and functional plasticity. Aberrations in NLGN1 levels or sequence are linked to multiple neurodevelopmental, neuropsychiatric, and neurodegenerative conditions, making it a significant molecule in the study of brain disorders and synaptic biology[1][2][3][4].
Experimental mechanisms: Modulation of synapse formation and maintenance via interference with neurexin–neuroligin binding or NLGN1 phosphorylation. Compounds or strategies designed to modify NLGN1-dependent signaling may influence glutamatergic synaptic function[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroligin-1 (NLGN1).